Policy Statement—Rabies-Prevention Policy Update:
New Reduced-Dose Schedule
http://pediatrics.aappublications.org/cgi/reprint/
abstract
The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.
Pediatrics 2011;127:785–787
www.pediatrics.org/cgi/doi/10.1542/peds.2011-0095
New Reduced-Dose Schedule
http://pediatrics.aappublications.org/cgi/reprint/
abstract
The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.
Pediatrics 2011;127:785–787
www.pediatrics.org/cgi/doi/10.1542/peds.2011-0095
No hay comentarios:
Publicar un comentario